Gray-market peptides can create risks beyond the peptide itself, raising concerns over product quality, purity, and inconsistent formulation
Drug interactions and concurrent medications While AOD 9604 has not been shown to interact significantly with most medications, the research on drug interactions remains limited

others take 2-3 weeks Mild injection site reactions (if applicable) are common and self-limited Phase 3: Active Healing Phase (Weeks 3-8) Progressive improvement in symptoms For musculoskeletal conditions, this is the optimal window for physical therapy and rehabilitation For GI conditions, patients often begin reintroducing previously problematic foods Phase 4: Consolidation (Weeks 9-12+) Continued structural healing Transition to maintenance dosing if appropriate Decision point for stacking with TB-500 if additional systemic support is needed Phase 5: Transition and Maintenance Tapering off peptides after goal achievement Maintenance protocols for chronic conditions (e.g., 3 months on, 1 month off) Coordination with long-term wellness strategies (nutrition, exercise, stress management) For more information on conditions that may benefit from this approach, visit my Conditions Treated page

The Best Way to Test for Vitamin B12 Deficiency A diagnosis of B12 deficiency should not be dismissed based solely on a single measurement